Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Vera Therapeutics Q2 EPS $(0.55) Down From $(0.33) YoY

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.55) per share. This is a 66.67 percent decrease over losses of $(0.33) per share from the same period last year.
byBenzinga Newsdesk
August 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Vera Therapeutics (NASDAQ:VERA) reported quarterly losses of $(0.55) per share. This is a 66.67 percent decrease over losses of $(0.33) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Exclusive: Kevin O’Leary, Gov. Burgum To Support Sustainable Innovation Via North Dakota Wonder Fund

By Renato Capelj
February 9, 1:15 PM
O’Leary Ventures’ chairman Kevin O’Leary is ditching the likes of New York and California for places where, he says, entrepreneurship and hard work are not punished by taxes and regulation. “It’s a trend that’s accelerating,” O’Leary tells Benzinga.

MSFT